Efficacy of Septilin Drops in Respiratory Disorders

An open clinical study to evaluate the safety and efficacy of septilin drops in the management of upper respiratory tract infection in infants and children

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/04/006864

Enrollment

Registered

2016-04-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with URTI symptoms like cough, cold, fever and devoid of serious illness requiring conventional treatment.

Interventions

Intervention1: Septilin drops Poly Herbal Formulation: Polyherbal formulation Each Ml contains Guggulu(Balsamodendronmukul) (purified) 47.4 mg Maharasnadiquath 17.8 mg Guduchi(Tinosporacordifolia) 8.3

Eligibility

Inclusion criteria

Inclusion criteria: above age group patients having URTI signs and symptoms

Exclusion criteria

Exclusion criteria: • Those with serious Cardiovascular, Cerebro vascular, Respiratory, Liver or Renal disease or any other disorder. • Children with congenital abnormality. • Subjects with a strong history of food or drug allergy of any kind. • During course of treatment if the subject develops any acute illness requiring acute management, such patients will be excluded out of the study and continued with conventional treatment.

Design outcomes

Primary

Measure	Time frame
Relieving of symptomsTimepoint: Assessment will be done on 7th , 15th , 30th,and 45th day during study	—

Secondary

Measure	Time frame
ImmunomodulationTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Pushpa Jogihalli

KLEUs B.M K Ayurveda Mahavidyalaya, Begaum

azizarbar@gmail.com9844532113

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026